AXON Neuroscience

AXON Neuroscience

Cyprus - Larnaca
Biotechnology

Focus: Tau Vaccine

AXON Neuroscience is a life sciences company focused on Tau Vaccine.

NeurologyInfectious DiseasesVaccines
Funding Stage
PUBLIC
Employees
51-200
Open Jobs
0

Pipeline & Clinical Trials

Aerobic Exercise
Brain Concussion
N/A
Clinical Trials (1)
NCT05498038Exercise Reset for Concussion in a Military Environment
N/A
Clinical Trials (1)
NCT03174886A 24-month Phase 1 Pilot Study of AADvac1 in Patients With Non Fluent Primary Progressive Aphasia
Phase 1
Phase 1
Clinical Trials (1)
NCT01850238Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease
Phase 1
Phase 1
Clinical Trials (1)
NCT0203119818-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease
Phase 1
Phase 2
Clinical Trials (1)
NCT0257925224 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease
Phase 2
Clinical Trials (1)
NCT07217665The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1
Phase 2
Clinical Trials (1)
NCT07167966Alzheimer's Tau Platform: Regimen A - AADvac1
Phase 2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Founded: 1999
Portfolio: 7 clinical trials